Company is still very attractive and underpriced ..Final Phase 3 readout of the Pancreatic cancer trial and BLA filing for the ALL indication both expected within next 3 months .If everything goes well this company likely to run toward 50 bucks and more. $Erytech Pharma S.A.(ERYP)$
精彩评论